Skip to contentClarengateINTELLIGENCE
Coverage & freshness About Clarengate
Companies/06606016

Life Science Group Limited

Manufacture of other chemical products n.e.c. · Radlett

ActiveUnited KingdomIncorporated 2008Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2026-05-31

IXBRL · 139 source facts · 22 selected values

Validation findings
XBRL invalid
Reporting period
2025-06-01 to 2026-05-31
Extraction status
complete
Numeric facts
77
Documents processed
1
XBRL standards validation
invalid
Filing-profile validation
invalid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2025-01-01.xsd
Currency
GBP
Source identifier
Prod224_2608_06606016_20260531
Source archive
Accounts_Monthly_Data-August2026.zip

Extraction findings: filing rules invalid; specification invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2025-05-31

IXBRL · 135 source facts · 22 selected values

Validation findings
XBRL invalid
Reporting period
2024-06-01 to 2025-05-31
Extraction status
complete
Numeric facts
73
Documents processed
1
XBRL standards validation
invalid
Filing-profile validation
invalid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2025-01-01.xsd
Currency
GBP
Source identifier
Prod224_2602_06606016_20250531
Source archive
Accounts_Monthly_Data-February2026.zip

Extraction findings: filing rules invalid; specification invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2024-05-31

IXBRL · 142 source facts · 24 selected values

Validation findings
XBRL valid
Reporting period
2023-06-01 to 2024-05-31
Extraction status
complete
Numeric facts
79
Documents processed
1
XBRL standards validation
valid
Filing-profile validation
invalid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2023-01-01.xsd
Currency
GBP
Source identifier
Prod224_3500_06606016_20240531
Source archive
Accounts_Monthly_Data-January2025.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2023-05-31

IXBRL · 135 source facts · 23 selected values

Not assessed
legacy record
Reporting period
2022-06-01 to 2023-05-31
Extraction status
Legacy / not assessed
Numeric facts
71
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2021-01-01.xsd
Currency
GBP
Source identifier
Prod224_1666_06606016_20230531
Source archive
Accounts_Monthly_Data-January2024.zip

Accounts to 2019-05-31

IXBRL · 72 source facts · 24 selected values

Not assessed
legacy record
Reporting period
2018-06-01 to 2019-05-31
Extraction status
Legacy / not assessed
Numeric facts
36
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0075_06606016_20190531
Source archive
Accounts_Monthly_Data-February2020.zip

Accounts to 2015-05-31

IXBRL · 60 source facts · 20 selected values

Not assessed
legacy record
Reporting period
2014-06-01 to 2015-05-31
Extraction status
Legacy / not assessed
Numeric facts
40
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
uk-gaap-full-2009-09-01.xsd
Currency
GBP
Source identifier
Prod224_0027_06606016_20150531
Source archive
Accounts_Monthly_Data-February2016.zip

Registered details

06606016
Status
Active
Type
Private Limited Company
Incorporated
2008-05-29
Jurisdiction
—
Registered office
137, WATLING STREET, RADLETT, HERTFORDSHIRE, WD7 7NQ, ENGLAND

Classification

4 SIC codes
20590211007211096090

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

4 matched grants
High Accuracy Multi-biomarker Screen for the Early Detection of Lung CancerLead
Innovate UK · Collaborative R&D · 2024-01-01 – 2026-03-31 · with 4 other participants
£142,241
awarded
Aberystwyth University£237,027
Highfield Diagnostics Ltd£169,303
Life Science Group Limitedlead£142,241
Protem Services Limited£130,684
Valley Diagnostics Limited£59,141
Development of Viral Inactivation Buffer for the transportation of viral contaminated samplesLead
Innovate UK · Feasibility Studies · 2020-06-01 – 2021-02-28
£49,876
awarded
Optically controlled fluid flow: enabling smart paper-based medical diagnostic devices
EPSRC · Research Grant · 2018-12-20 – 2021-12-19 · with 3 other participants
£438,973
whole project
University of SouthamptonleadDSTL Porton DownLife Science Group LtdPublic Health England
Coventry University and Life Science Group Limited
Innovate UK · Knowledge Transfer Partnership · 2018-02-01 – 2021-05-31 · with 1 other participant
Coventry Universitylead£155,230
Life Science Group Limited—